ArticleBritish journal of pharmacology2024

A novel EGFR inhibitor, HNPMI, regulates apoptosis and oncogenesis by modulating BCL-2/BAX and p53 in colon cancer.

Jeyalakshmi Kandhavelu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.